~~<i id='EFE2F0A87B'><strike id='EFE2F0A87B'><tt id='EFE2F0A87B'><pre id='EFE2F0A87B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

fashion

author：focus 2025-09-06 04:41:48 - browse：8193

Two Vertex buidings in the Seaport District — David L Ryan/Globe Staff

When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

Now, Vertex may be on the move again.

With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

leisure time

focus

hotspot

focus

entertainment

hotspot

JustinKlee(left)andJoshuaCohenaretheco-foundersandco-CEOsofAmylyxPharmaceuticals.KayanaSzymczakforST

WSS

First medicine developed to treat MASH expected to be approved soon

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Precocious puberty in girls comes with mental health risks

With psoriasis trial ahead, Alumis raises $259 million

Change Healthcare payments predicted restored March 15

leisure time

fashion

leisure time

Medical leaders decry Supreme Court decision on affirmative action

Change Healthcare payments predicted restored March 15

As demand for Covid shots wanes, Moderna seeks its next success

UnitedHealth quietly bought dozens of outpatient centers

Cancer drug shortages should be causing more outrage

IVF, abortion rights issues kick off Biden’s State of the Union

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

How to save PrEP access — and even expand it

In his State of the Union, Biden takes clear aim at 'Big Pharma'

focus

Change Healthcare payments predicted restored March 15

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

The problem with charging patients to message their doctors

Just how do doctors, lawmakers, and the public define abortion?

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

hotspot

focus

entertainment

hotspot